Rockets Wire on MSN
Rockets 'aren't completely ruling out' Fred VanVleet return this year
Houston has missed Fred VanVleet this season at the point, but the Rockets are hopeful he could make a "late-season return" ...
Contested shelter, city-backed developments highlight the year to come in affordable housing options as Boise adds low-cost ...
The City of Greer will mark its sesquicentennial with Greer150, a year-long celebration throughout 2026. Monthly programs ...
The Reader on MSN
Veteran theater-maker Vincent Orduña enjoys homecoming as new Omaha Community Playhouse artistic director
Since his official July 1 start, Vincent “VJ” Orduña has made history as the first African American to serve as artistic ...
The overall fact pattern suggested by Friedman’s Sherwood report, bolstered by the context that a sizeable gap remains, and ...
Seattle magazine on MSN
Welcome to the Moll House
Learn about Amanda and Hana Moll, twins who excel in pole vaulting, showcasing incredible skill and teamwork in every jump.
Here are improbable, but not impossible, landing spots for the top 10 remaining MLB free agents after Kazuma Okamoto and ...
Amid a challenging environment, the company’s best-in-class asset base — anchored by its highly differentiated Megacampus ...
FinanceBuzz on MSN
These 8 states lead the nation in auto theft (are you at risk?)
The data is in. These states have the highest auto theft rates in the country. You'll also find some city-specific ...
Enveda Biosciences was recently cleared to begin clinical trials of its drug candidate for the treatment of inflammatory bowel disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results